Results
427
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
427 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BKE | US$43.06 | -3.3% | 32.6% | US$2.2b | US$31.00 | PE10.4x | E-0.9% | 9.1% | ||
KSS | US$19.76 | 5.5% | -0.3% | US$2.1b | US$21.89 | PE7.7x | E6.5% | 10.1% | ||
VSCO | US$27.01 | 11.3% | 60.1% | US$2.1b | US$23.88 | PE15.4x | E7.6% | n/a | ||
CWH | US$24.72 | 1.5% | 25.5% | US$2.0b | US$26.73 | PB10.5x | E128.9% | 2.0% | ||
ALTB | US$2.02 | 0% | n/a | US$2.0b | n/a | PS15504x | n/a | n/a | ||
SAH | US$57.44 | 1.6% | 17.5% | US$2.0b | US$63.25 | PE10.3x | E13.8% | 2.1% | ||
APE | AU$10.70 | 3.0% | -22.7% | AU$2.7b | AU$11.63 | PE10.6x | E1.8% | 6.9% | ||
ARHS | US$12.54 | -5.0% | 38.1% | US$1.9b | US$14.73 | PE20x | E7.6% | n/a | ||
PETS | UK£2.99 | -2.1% | -12.2% | UK£1.4b | UK£3.59 | PE17.3x | E13.2% | 4.3% | ||
RVLV | US$25.89 | 5.7% | 100.5% | US$1.8b | US$22.19 | PE55.5x | E23.0% | n/a | ||
WRBY | US$15.22 | 2.3% | 21.4% | US$1.7b | US$16.93 | PS2.5x | E116.2% | n/a | ||
SVV | US$10.53 | 1.2% | -45.1% | US$1.7b | US$14.13 | PE45.1x | E41.9% | 0% | ||
UPBD | US$30.85 | 0.3% | 6.2% | US$1.7b | US$42.25 | PE30.8x | E28.7% | 4.8% | ||
LNF | CA$29.89 | 0.3% | 54.4% | CA$2.0b | CA$37.50 | PE13.8x | E2.8% | 2.4% | ||
PET | CA$24.99 | -4.3% | 3.9% | CA$1.9b | CA$32.67 | PE21.9x | E18.3% | 1.8% | ||
SBH | US$13.33 | -0.9% | 62.8% | US$1.4b | US$11.20 | PE9.2x | E19.7% | n/a | ||
WOSG | UK£4.06 | 0.9% | -26.4% | UK£973.6m | UK£4.91 | PE16.5x | E19.5% | n/a | ||
WINA | US$373.00 | 0.1% | 2.0% | US$1.3b | US$445.00 | PE32.7x | E6.8% | 3.5% | ||
EVGO | US$4.13 | -12.1% | 24.4% | US$1.2b | US$4.90 | PS2.1x | E31.3% | n/a | ||
CURY | UK£0.84 | 5.2% | 74.1% | UK£912.7m | UK£1.01 | PE33.8x | E20.5% | 0% | ||
SCVL | US$44.97 | 2.4% | 97.1% | US$1.2b | US$50.50 | PE15.8x | E7.8% | 1.2% | ||
WOOF | US$4.39 | -10.8% | 17.4% | US$1.2b | US$3.31 | PB1.1x | E123.6% | n/a | ||
BAP | AU$5.19 | 3.0% | -23.8% | AU$1.8b | AU$5.43 | PB2x | E53.2% | 2.9% | ||
CAL | US$32.40 | -1.4% | 20.0% | US$1.1b | US$36.67 | PE7.3x | E2.1% | 0.9% |